# About the Evidence Desk

> About Peaceful Peptides — Research Peptide Fundamentals — How Peaceful Peptides edits Research Peptide Fundamentals research peptides: model-first summaries, exact citations, and restrained conclusions.

**EDITORIAL METHOD / CALM CLAIMS**

An independent digest designed to make study design, measured outcomes, and uncertainty easier to see.

## What Peaceful Peptides is

Peaceful Peptides is an independent editorial digest of research on KPV, NAD+, BPC-157, and GHK-Cu. The four-compound roster is intentional: it exposes how easily one broad label can conceal very different molecules and evidence bases. KPV and GHK-Cu are tripeptides, BPC-157 is a longer synthetic peptide, and NAD+ is a cellular coenzyme rather than a peptide. Their main literatures range from inflammatory animal models to human precursor trials and topical skin research.

The site’s job is to make those differences visible. It does not sell, source, rank, or endorse compounds. It is not a clinic, a supplement guide, or a dosing manual. Each technical page begins with a plain-English orientation, then moves into identity, mechanism, findings, cautions, and the compound’s place in the shared evidence frame. The [comparison page](/compare) is organized by study model and evidence maturity rather than promotional category.

## How the record is read

The editorial method uses three columns: **measured benefit, adverse or cautionary finding, unresolved question**. A measured result is kept in its original setting. Cell signaling stays cell signaling. A mouse colitis outcome stays a mouse colitis outcome. A blood biomarker does not quietly become a longevity result. A combination product does not become proof for one ingredient.

Numbers appear with citations. Study design and population are stated when they change interpretation. Review articles are distinguished from primary experiments. Community experiences are labeled **anecdotal, not clinical evidence** and never carry a recommended dose or schedule. Regulatory status is reported separately from mechanism: biological activity does not confer approval, while approval status alone does not explain a pathway.

This approach is intentionally conservative. It allows an interesting result to remain interesting without inflating it into certainty. It also allows a negative, null, or unresolved finding to remain visible rather than being treated as inconvenient background.

## What the desk does not decide

This digest cannot determine whether any compound is suitable for a person, diagnose a condition, interpret symptoms, or recommend use. It does not validate material sold outside regulated research or clinical channels. It does not infer product purity from a label, and it does not turn community frequency words into incidence rates.

The source ledger is finite and transparent. Its twenty-two references are gathered on the [references page](/references), grouped by compound through stable identifiers in the underlying corpus. Editorial corrections are welcome when they can be checked against a primary or peer-reviewed source. New findings may change the balance, especially in areas with tiny human samples; until they do, the uncertainty shown on the page is part of the answer.

---

An independent evidence ledger for four often-overstated compounds—measured findings and uncertainty, never a prescription.